Review



human pancreatic cancer cell lines capan-2  (DS Pharma Biomedical)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    DS Pharma Biomedical human pancreatic cancer cell lines capan-2
    Human Pancreatic Cancer Cell Lines Capan 2, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pancreatic+cancer+cell+lines+capan-2/pm39419752-71-2-19?v=DS+Pharma+Biomedical
    Average 90 stars, based on 1 article reviews
    human pancreatic cancer cell lines capan-2 - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    human pancreatic cancer cell lines  (ATCC)
    94
    ATCC human pancreatic cancer cell lines
    Figure 1. Baseline expression of LGR6 in PDAC cell lines. (A) qPCR of epithelial (CDH1), mesenchymal (ZEB1) markers, and LGR6. In addition, sphere-formation capacity (SFA) was evaluated. (B) Morphology of defined epithelial and mesenchymal PDAC cell lines; (C) Immunohistochemistry (left panels, Protein atlas) and immunofluorescence staining LGR6 (green) and E-cadherin (red) in <t>Capan2;</t> (D) Western blot analysis of LGR6 in <t>pancreatic</t> cancer cell lines. Quantification is shown as normalized to Capan2; (E) Flow cytometric analysis of extra- and intra-cellular LGR6 in pancreatic cancer cell lines; (F) Clustering analysis of the TCGA databank on PDAC identified LGR6 with epithelial marker group *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.
    Human Pancreatic Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pancreatic+cancer+cell+lines+capan-2/pm37770230-41-0-12?v=ATCC
    Average 94 stars, based on 1 article reviews
    human pancreatic cancer cell lines - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    human pancreatic cancer cell lines capan-2  (DS Pharma Biomedical)
    90
    DS Pharma Biomedical human pancreatic cancer cell lines capan-2
    Figure 1. Baseline expression of LGR6 in PDAC cell lines. (A) qPCR of epithelial (CDH1), mesenchymal (ZEB1) markers, and LGR6. In addition, sphere-formation capacity (SFA) was evaluated. (B) Morphology of defined epithelial and mesenchymal PDAC cell lines; (C) Immunohistochemistry (left panels, Protein atlas) and immunofluorescence staining LGR6 (green) and E-cadherin (red) in <t>Capan2;</t> (D) Western blot analysis of LGR6 in <t>pancreatic</t> cancer cell lines. Quantification is shown as normalized to Capan2; (E) Flow cytometric analysis of extra- and intra-cellular LGR6 in pancreatic cancer cell lines; (F) Clustering analysis of the TCGA databank on PDAC identified LGR6 with epithelial marker group *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.
    Human Pancreatic Cancer Cell Lines Capan 2, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pancreatic+cancer+cell+lines+capan-2/pm39419752-71-2-19?v=DS+Pharma+Biomedical
    Average 90 stars, based on 1 article reviews
    human pancreatic cancer cell lines capan-2 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    human pancreatic cancer cell lines capan 2  (ATCC)
    97
    ATCC human pancreatic cancer cell lines capan 2
    Figure 1. Baseline expression of LGR6 in PDAC cell lines. (A) qPCR of epithelial (CDH1), mesenchymal (ZEB1) markers, and LGR6. In addition, sphere-formation capacity (SFA) was evaluated. (B) Morphology of defined epithelial and mesenchymal PDAC cell lines; (C) Immunohistochemistry (left panels, Protein atlas) and immunofluorescence staining LGR6 (green) and E-cadherin (red) in <t>Capan2;</t> (D) Western blot analysis of LGR6 in <t>pancreatic</t> cancer cell lines. Quantification is shown as normalized to Capan2; (E) Flow cytometric analysis of extra- and intra-cellular LGR6 in pancreatic cancer cell lines; (F) Clustering analysis of the TCGA databank on PDAC identified LGR6 with epithelial marker group *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.
    Human Pancreatic Cancer Cell Lines Capan 2, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pancreatic+cancer+cell+lines+capan-2/pm36572921-70-0-21?v=ATCC
    Average 97 stars, based on 1 article reviews
    human pancreatic cancer cell lines capan 2 - by Bioz Stars, 2026-08
    97/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. Baseline expression of LGR6 in PDAC cell lines. (A) qPCR of epithelial (CDH1), mesenchymal (ZEB1) markers, and LGR6. In addition, sphere-formation capacity (SFA) was evaluated. (B) Morphology of defined epithelial and mesenchymal PDAC cell lines; (C) Immunohistochemistry (left panels, Protein atlas) and immunofluorescence staining LGR6 (green) and E-cadherin (red) in Capan2; (D) Western blot analysis of LGR6 in pancreatic cancer cell lines. Quantification is shown as normalized to Capan2; (E) Flow cytometric analysis of extra- and intra-cellular LGR6 in pancreatic cancer cell lines; (F) Clustering analysis of the TCGA databank on PDAC identified LGR6 with epithelial marker group *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.

    Journal: Aging

    Article Title: WNT enhancing signals in pancreatic cancer are transmitted by LGR6.

    doi: 10.18632/aging.205101

    Figure Lengend Snippet: Figure 1. Baseline expression of LGR6 in PDAC cell lines. (A) qPCR of epithelial (CDH1), mesenchymal (ZEB1) markers, and LGR6. In addition, sphere-formation capacity (SFA) was evaluated. (B) Morphology of defined epithelial and mesenchymal PDAC cell lines; (C) Immunohistochemistry (left panels, Protein atlas) and immunofluorescence staining LGR6 (green) and E-cadherin (red) in Capan2; (D) Western blot analysis of LGR6 in pancreatic cancer cell lines. Quantification is shown as normalized to Capan2; (E) Flow cytometric analysis of extra- and intra-cellular LGR6 in pancreatic cancer cell lines; (F) Clustering analysis of the TCGA databank on PDAC identified LGR6 with epithelial marker group *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.

    Article Snippet: Human pancreatic cancer cell lines (BxPC3, Capan2, MiaPaCa2, Panc1) were obtained from American Type Culture Collection (ATCC).

    Techniques: Expressing, Immunohistochemistry, Immunofluorescence, Staining, Western Blot, Marker

    Figure 2. LGR6 expression correlates with epithelial signatures. (A) Super TOP/FOP assays (STF assay) revealed higher baseline WNT activity levels in epithelial (green) vs. mesenchymal (blue) pancreatic cancer cells. (B) Clustering of gene expression in the same cell lines affiliates LGR6 with WNTpositive epithelial signature, whereas the WNTnegative mesenchymal signature was highly expressed in mesenchymal PDAC cell lines (blue). (C) Epithelial WNT niche subtypes described by Seino and colleagues clustered with LGR6 in CCLE and TCGA datasets. *, P<0.05; **, P<0.01; ***, P<0.001.

    Journal: Aging

    Article Title: WNT enhancing signals in pancreatic cancer are transmitted by LGR6.

    doi: 10.18632/aging.205101

    Figure Lengend Snippet: Figure 2. LGR6 expression correlates with epithelial signatures. (A) Super TOP/FOP assays (STF assay) revealed higher baseline WNT activity levels in epithelial (green) vs. mesenchymal (blue) pancreatic cancer cells. (B) Clustering of gene expression in the same cell lines affiliates LGR6 with WNTpositive epithelial signature, whereas the WNTnegative mesenchymal signature was highly expressed in mesenchymal PDAC cell lines (blue). (C) Epithelial WNT niche subtypes described by Seino and colleagues clustered with LGR6 in CCLE and TCGA datasets. *, P<0.05; **, P<0.01; ***, P<0.001.

    Article Snippet: Human pancreatic cancer cell lines (BxPC3, Capan2, MiaPaCa2, Panc1) were obtained from American Type Culture Collection (ATCC).

    Techniques: Expressing, Activity Assay, Gene Expression

    Figure 5. LGR6 is higher expressed in PDAC compared to normal tissue and trends towards worse overall survival. (A) Analysis of publicly available datasets (GSE62165, GSE16515, and GSE71729) shows significantly more LGR6 in tumor vs. normal pancreatic tissue (NP). (B) ROC curve analysis of normalized LGR6 mRNA expression for best discrimination threshold with an area under the curve (AUC) of 0.6565. (C) Dichotomal classification revealed a trend of high LGR6 expression and poor overall survival; survival of PDAC patients of LGR6high

    Journal: Aging

    Article Title: WNT enhancing signals in pancreatic cancer are transmitted by LGR6.

    doi: 10.18632/aging.205101

    Figure Lengend Snippet: Figure 5. LGR6 is higher expressed in PDAC compared to normal tissue and trends towards worse overall survival. (A) Analysis of publicly available datasets (GSE62165, GSE16515, and GSE71729) shows significantly more LGR6 in tumor vs. normal pancreatic tissue (NP). (B) ROC curve analysis of normalized LGR6 mRNA expression for best discrimination threshold with an area under the curve (AUC) of 0.6565. (C) Dichotomal classification revealed a trend of high LGR6 expression and poor overall survival; survival of PDAC patients of LGR6high

    Article Snippet: Human pancreatic cancer cell lines (BxPC3, Capan2, MiaPaCa2, Panc1) were obtained from American Type Culture Collection (ATCC).

    Techniques: Expressing